Ben:
Your opinion is no longer humble.
I include my last post on the thread; it regards an analyst's write-up of RECY (the first), and quite possibly the hanging curve you need for your next 500-footer:
The guy at wmsmith is nammed Warrick. He wrote the report and loves the stock. He's more than eager to talk about RECY and knows a ton. His number is (303) 831-9696. (Yes, he's a next-door neighbor to Skip, Luke, Michael, and all the boys.)
Smith sent it out yesterday to 150 clients: mutual funds, hedge funds, and money managers. He has a target price of $15 for the 12 months, and he agreed with me that it might be a bit conservative; in esse, he's hedging his bets until word about the financing comes through and is read by the street. He's hopeful that much of the financing will be on preferred, irredeemable for one to three years (he says there's no boiler-plate when it comes to such equities); he says there may be some dilution, but didn't think it would be excessive. Basically, the financial end boils down to Botica; it was his connections that seem to have really enabled the co to turn this corner.
Smith does not make markets, though they anticipate doing so in the future; they are a brokerage as well. Warrick personally owns what he calls a "small stake." The company is forbidden from acquiring any shares for the next three weeks.
During that time, I guess we'll see just how big a stick these guys swing with their insitututional clients.
In the meantime, the next great hurdle has been leaped: We have a write-up from an analyst, and the Street, already briefed [by Weins' recent trip to NY], is now in possession of an 8 to 10 page GLOWING REPORT ON RECY.
Ivan
GO RECY GO RECY GO RECY GO!!!!!! |
